Internal Medicine, Medical Oncology · Houston, TX
NPI
1013064823
Since 2007
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1515 Holcombe Blvd
Houston, TX, 77030
Phone (713) 792-6161
Groups this clinician bills Medicare through
Medicare paid, 2024
$23K
231 services
Medicare patients, 2024
132
Average age 70
Drug cost, 2024
$662K
139 prescriptions
Company payments, 2025
$3,317
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Paula R Pohlmann was code 99215 (office e&m - established), 115 times for 75 patients. In total Paula R Pohlmann billed 231 services in 13 codes, and Medicare paid $23K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-01-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 115 | 75 | $107.65 | $12K |
| 99214 Office E&M - Established | Facility | 49 | 35 | $71.05 | $3,481 |
| 99205 Office E&M - New | Facility | 20 | 20 | $137.94 | $2,759 |
By year: 2022 $33K for 317 services; 2023 $32K for 317 services; 2024 $23K for 231 services.
Medicare prescription drug claims, 2024
In 2024, the drug Paula R Pohlmann prescribed most often to Medicare patients was Anastrozole, with 26 prescriptions and refills. In total Paula R Pohlmann wrote 139 Medicare prescriptions that cost $662K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 26 | 62 | 12 | $466 |
| Ibrance Palbociclib | 22 | 22 | Under 11 | $323K |
| Nerlynx Neratinib Maleate | 15 | 15 | Under 11 | $301K |
| Letrozole Generic | 15 | 33 | Under 11 | $467 |
| Gabapentin Generic | 11 | 11 | Under 11 | $47.07 |
Brand drugs: 44 claims; generic drugs: 95 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Paula R Pohlmann $3,317 ($2,047 in general payments such as food, travel and fees and $1,270 for research) from 4 companies. The largest payer was Pfizer Inc. with $3,160.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.